Hanwha General Insurance announced on the 25th that it will sell the 'Non-dividend LifePlus (LIFEPLUS) Cancer Insurance That Protects You from the Beginning,' which covers everything from precancerous conditions to home hospice palliative care.

Hanwha General Insurance announced on the 25th that it will sell the 'Non-dividend LifePlus (LIFEPLUS) Cancer Insurance That Protects You from the Beginning,' which covers everything from precancerous conditions to home hospice palliative care.

View original image


[Asia Economy Reporter Oh Hyung-gil] Hanwha General Insurance announced on the 25th that it will sell the non-dividend LIFEPLUS "Cancer Insurance That Protects You From the Beginning," which covers everything from precancerous conditions to home hospice palliative care.


With cancer diagnosis benefits as the basic contract, it covers fundamental risks related to cancer such as similar cancer diagnosis benefits (other skin cancer, thyroid cancer, carcinoma in situ, borderline tumors), continuous cancer diagnosis benefits, surgery costs, hospitalization costs, chemotherapy, radiation therapy, and anticancer drug treatment costs.


For the first time in the industry, five new coverages have been added: cancer-specific rehabilitation treatment costs, cancer-specific pain relief treatment costs, terminal cancer hospice pain relief treatment costs (home-based), specific virus disease diagnosis benefits, and surgery costs for benign tumors and polyps in eight specific organs.


It newly covers surgery costs for benign tumors and polyps in eight specific organs, which are precancerous diseases, and diagnosis benefits for specific viruses that can cause cancer, thereby covering precancerous conditions as well.


To alleviate the pain of cancer patients, it also newly provides cancer pain relief treatment benefits for cases prescribed nerve block, neurolysis, or narcotic analgesics for more than 30 days annually, and cancer rehabilitation treatment benefits to treat structural damage and functional disabilities caused by cancer treatment.


In particular, hospice patient pain relief treatment previously required hospitalization at the relevant facility for coverage, but now home-based hospice pain relief treatment has been added.


The eligible age for subscription is from 6 to 80 years old, and the insurance period can be 10, 20, or 30 years, with renewal possible up to age 100.



Ahn Kwang-jin, head of the Long-term Insurance Team at Hanwha General Insurance, said, "This cancer insurance thoroughly covers everything from prevention, diagnosis, treatment, rehabilitation, to hospice care for terminal patients, ensuring protection from precancerous conditions to returning to work after a cancer diagnosis."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing